Solventum Corporation (NYSE: SOLV) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $14.6B. The Maz Rating grades it against the other companies in its sector.
Solventum Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $86.06, Solventum Corporation trades at 97.5x trailing earnings, 1.8x sales and 3.1x book value, with an EV/EBITDA of 24.3. Over the last twelve months it generated about $8.1B of revenue and $150M of net income. It runs a gross margin of 54.3%, an operating margin of 24.6% and a net margin of 1.9%. It shows return on equity of 3.2%, return on invested capital of 16.6% and a free cash flow yield of 0.0%. On the balance sheet: a debt-to-equity ratio of 1.10 and a current ratio of 1.03. Over the past 52 weeks the share price ranged from $62.38 to $94.16, with a beta of 0.75.
Solventum Corporation does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 9 Buy, 2 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.